Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats

Area of Science:

• Toxicology
• In Vitro Assays
• Cell Biology

Background:

• Reducing animal testing in toxicity studies is crucial, aligning with the 3Rs principles.
• Developing reliable in vitro alternatives for acute inhalation toxicity assessment is essential.

Purpose of the Study:

• To develop and validate a neutral red uptake (NRU) assay using A549 human lung cells (A549-NRU) as a predictive model for acute inhalation toxicity.
• To assess the correlation of the A549-NRU assay with in vivo rat inhalation toxicity data.

Main Methods:

• Developed a 15-minute incubation NRU assay using A549 cells, employing both polystyrene and glass plates.
• Determined LC50 values for 49 chemicals using the A549-NRU assay.
• Compared A549-NRU derived LC50 values with reported in vivo rat LC50 values and conventional mouse 3T3 NRU assay results.

Main Results:

• The A549-NRU assay showed significant positive correlations with in vivo LC50 values for water-soluble compounds (r=0.4632) and specific chemical groups (aldehydes/ketones: r=0.9339; alcohols/ethers/epoxides: r=0.7668).
• The A549-NRU assay demonstrated a stronger correlation (r=0.8879) with in vivo data compared to the conventional mouse 3T3 NRU assay (r=0.4524).
• The assay's predictive capability suggests potential for estimating starting doses in in vivo studies.

Conclusions:

• The A549-NRU assay is a viable in vitro alternative for predicting acute inhalation toxicity.
• This assay offers a more accurate prediction of in vivo toxicity compared to the conventional NRU assay.
• Findings support the use of the A549-NRU assay for toxicity testing and reducing animal use.